Portfolio company
ACS Biomarker
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides biomarker discovery and validation services for cardiovascular disease diagnostics to academic research groups and pharmaceutical industry partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Rapidscan
This company develops biopharmaceutical stress agents used for cardiovascular disease diagnosis in healthcare settings.
CardiNor
This company develops secretoneurin blood assays for laboratories and researchers to assess risk in patients with cardiovascular disease.
Cardiatech Bio
The company develops a computational platform to discover cardiovascular drug targets using multi-omics data for the pharmaceutical and biotechnology industries.
Argonaute RNA
This biotechnology firm develops bispecific siRNA therapeutics for cardiometabolic diseases, serving pharmaceutical partners and research institutions engaged in advanced therapeutic research.
Cardiatec
This company develops an artificial intelligence platform to identify novel drug targets and therapeutics for cardiovascular diseases for the pharmaceutical and healthcare industries.
CardiaTec Biosciences
This company develops an artificial intelligence platform to identify cardiovascular drug targets for pharmaceutical providers using large-scale multi-omics data.
Precision for Medicine
This company provides biomarker-driven clinical research and development services for pharmaceutical and biotechnology organisations to accelerate the commercialisation of personalised medicines.
Boston Heart Diagnostics
The company provides cardiovascular diagnostic tests and personalised nutrition programmes to healthcare providers and patients to manage heart disease risk.